Manifold Bio is a protein drug discovery platform focused on developing technologies that increase measurement throughput during the drug development phase, thereby accelerating drug discovery progress. Manifold Bio announced a $40 million Series A round led by Triatomic Capital.
This article is reproduced from: https://www.itjuzi.com/investevent/13354456
This site is for inclusion only, and the copyright belongs to the original author.